Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era

• Main Authors: Sara Madureira Gomes (Author), Rita Pissarra Teixeira (Author), Gustavo Rocha (Author), Paulo Soares (Author), Hercilia Guimaraes (Author), Paulo Santos (Author), Joana Jardim (Author), João Luís Barreira (Author), Helena Pinto (Author)
• Format: Book
• Published: Thieme Medical Publishers, Inc., 2021-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The atypical hemolytic uremic syndrome (aHUS) in the newborn is a rare disease, with high morbidity. Eculizumab, considered a first-line drug in older children, is not approved in neonates and in children weighing less than 5 kg. We present a 5-day-old female newborn, born at 36 weeks' twin ges...